ADAMAX
Essentially no published research exists - this appears to be primarily discussed in research chemical circles rather than academic literature. Any effects remain purely theoretical.
Primarily found in nootropics research communities and specialized peptide laboratories investigating ACTH-derived compounds.
Since Feb 2026
0 total
What is ADAMAX?
Part of a family of ACTH-derived synthetic peptides being explored for their effects on brain function and cognition. Researchers consider it a modified version of Semax, engineered with structural changes intended to enhance stability and bioavailability. Most investigation occurs within specialized nootropics research labs and neurochemistry departments.
Works as a modified fragment of adrenocorticotropic hormone (ACTH) that appears to interact with melanocortin receptors in the brain. The peptide may stimulate the production of brain-derived neurotrophic factor (BDNF), a protein crucial for neuron growth and survival, while also affecting dopamine and serotonin pathways that influence focus and mental processing.
Reported Benefits
Regulatory Status
Last verified: Feb 2026
Related Peptides
This information is for research purposes only and does not constitute medical advice. Always consult a licensed physician before using any peptides.